PRODIGE 20: Bevacizumab plus chemotherapy (BEV-CT) versus chemotherapy alone (CT) in elderly patients (pts) with untreated metastatic colorectal cancer (mCRC)-A randomized phase II trial.

Affiliation auteurs!!!! Error affiliation !!!!
TitrePRODIGE 20: Bevacizumab plus chemotherapy (BEV-CT) versus chemotherapy alone (CT) in elderly patients (pts) with untreated metastatic colorectal cancer (mCRC)-A randomized phase II trial.
Type de publicationJournal Article
Year of Publication2015
AuteursAparicio T, Bouche O, Francois E, Maillard E, Kirscher S, Taieb J, Etienne P-L, Faroux R, Khemissa F, Hajbi FEl, Locher C, Rinaldi Y, Lecomte T, Lavau-Denes S, Baconnier M, Oden-Gangloff A, Genet D, Paillaud E, Retornaz F, Bedenne L
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume33
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/jco.2015.33.15_suppl.3541